MiMedx signs $25M license deal with undisclosed wound care competitor to settle patent infringement allegations

MiMedx Group has signed a $25 million license deal with an undisclosed wound care competitor to settle allegations of infringement of MiMedx's patents.

Detected & updated continuously · Source: Nebula